AR093425A1 - Cepa de lactobacillus rhamnosus para reducir la acumulacion de grasa corporal - Google Patents
Cepa de lactobacillus rhamnosus para reducir la acumulacion de grasa corporalInfo
- Publication number
- AR093425A1 AR093425A1 ARP130104120A ARP130104120A AR093425A1 AR 093425 A1 AR093425 A1 AR 093425A1 AR P130104120 A ARP130104120 A AR P130104120A AR P130104120 A ARP130104120 A AR P130104120A AR 093425 A1 AR093425 A1 AR 093425A1
- Authority
- AR
- Argentina
- Prior art keywords
- lactobacillus rhamnosus
- cepa
- fat accumulation
- body fat
- reduce body
- Prior art date
Links
- 241000218588 Lactobacillus rhamnosus Species 0.000 title abstract 3
- 238000009825 accumulation Methods 0.000 title abstract 3
- 210000000577 adipose tissue Anatomy 0.000 title 1
- 208000008589 Obesity Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 208000035475 disorder Diseases 0.000 abstract 2
- LWGJTAZLEJHCPA-UHFFFAOYSA-N n-(2-chloroethyl)-n-nitrosomorpholine-4-carboxamide Chemical compound ClCCN(N=O)C(=O)N1CCOCC1 LWGJTAZLEJHCPA-UHFFFAOYSA-N 0.000 abstract 2
- 235000020824 obesity Nutrition 0.000 abstract 2
- 206010033307 Overweight Diseases 0.000 abstract 1
- 235000015872 dietary supplement Nutrition 0.000 abstract 1
- 235000013305 food Nutrition 0.000 abstract 1
- 235000020825 overweight Nutrition 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
- A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/175—Rhamnosus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K2035/11—Medicinal preparations comprising living procariotic cells
- A61K2035/115—Probiotics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Nutrition Science (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Child & Adolescent Psychology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Dairy Products (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Utilización de la cepa CNCM I-3690 de Lactobacillus rhamnosus para la reducción de la acumulación de grasa en el cuerpo y el tratamiento de trastornos que son resultados de esa acumulación, tales como el sobrepeso, la obesidad y los trastornos relacionados con la obesidad. Reivindicación 5: La cepa CNCM I-3690 de Lactobacillus rhamnosus para el uso que se indica en la reivindicación 4, que se caracteriza porque la mencionada composición es un producto alimenticio o un suplemento alimenticio.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/IB2012/056344 WO2014072771A1 (en) | 2012-11-12 | 2012-11-12 | Lactobacillus rhamnosus strain for reducing body fat accumulation |
Publications (1)
Publication Number | Publication Date |
---|---|
AR093425A1 true AR093425A1 (es) | 2015-06-10 |
Family
ID=47356248
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP130104120A AR093425A1 (es) | 2012-11-12 | 2013-11-08 | Cepa de lactobacillus rhamnosus para reducir la acumulacion de grasa corporal |
Country Status (10)
Country | Link |
---|---|
US (1) | US9855304B2 (es) |
EP (1) | EP2925333A1 (es) |
JP (1) | JP2016507216A (es) |
CN (1) | CN104955467A (es) |
AR (1) | AR093425A1 (es) |
BR (1) | BR112015010639A2 (es) |
CA (1) | CA2890574A1 (es) |
MX (1) | MX2015005897A (es) |
RU (1) | RU2015122728A (es) |
WO (1) | WO2014072771A1 (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101864347B1 (ko) * | 2017-09-06 | 2018-06-05 | 주식회사 지놈앤컴퍼니 | 락토바실러스 람노수스 lm1019 균주 및 이를 포함하는 비만 또는 당뇨병 예방 및 치료용 조성물 |
CN109757730B (zh) * | 2019-01-31 | 2021-06-04 | 山东环亿生物科技有限公司 | 一种具有降血脂、血压以及血糖的组合物及其制备方法 |
CN113750113B (zh) * | 2020-06-01 | 2022-12-02 | 山东新时代药业有限公司 | 一种益生菌和益生元的组合物及其应用 |
CN112442463A (zh) * | 2020-11-25 | 2021-03-05 | 北京科拓恒通生物技术股份有限公司 | 鼠李糖乳杆菌Probio-M9及其制剂用于制备延长寿命制品的应用 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7001756B1 (en) * | 2004-02-19 | 2006-02-21 | Genmont Biotech Inc. | Microorganism strain of GM-020 of Lactobacillus rhamnosus and its use for treating obesity |
KR100686557B1 (ko) | 2004-08-16 | 2007-02-23 | 씨제이 주식회사 | 체지방 저하 기능성 락토바실러스 람노서스와 이를 함유한 식품 |
US20100216212A1 (en) | 2005-07-26 | 2010-08-26 | School Corp., Azabu Veterin Med. Educa'l Institu | Anti-obesity agent and anti-obesity food |
SE529185C2 (sv) | 2005-10-07 | 2007-05-22 | Arla Foods Amba | Användning av probiotiska bakterier för tillverkning av livsmedel eller läkemedel för förhindrande av övervikt |
JP2009524640A (ja) * | 2006-01-27 | 2009-07-02 | ダニスコ エー/エス | 肥満及びそれに関連する疾患の治療及び予防のためのプロバイオティック微生物の使用 |
EP2011506A1 (en) * | 2007-07-05 | 2009-01-07 | Nestec S.A. | Supplementation of maternal diet |
EP2022502A1 (en) | 2007-08-10 | 2009-02-11 | Nestec S.A. | Lactobacillus rhamnosus and weight control |
FR2928935B1 (fr) * | 2008-03-19 | 2011-05-20 | Gervais Danone Sa | Souche de lactobacillus rhamnosus. |
EP2216035A1 (en) | 2009-02-10 | 2010-08-11 | Nestec S.A. | Lactobacillus rhamnosus CNCM I-4096 and weight control |
FI123157B (fi) * | 2009-05-12 | 2012-11-30 | Valio Oy | Probioottien uusi käyttö |
EA024911B1 (ru) | 2010-01-08 | 2016-11-30 | Компани Жервэ Данон | Лактобациллы с антиоксидантным действием |
WO2011148219A1 (en) | 2010-05-28 | 2011-12-01 | Compagnie Gervais Danone | Probiotic strains for use in improving the enteric nervous system |
-
2012
- 2012-11-12 RU RU2015122728A patent/RU2015122728A/ru not_active Application Discontinuation
- 2012-11-12 EP EP12799635.3A patent/EP2925333A1/en not_active Withdrawn
- 2012-11-12 JP JP2015541243A patent/JP2016507216A/ja active Pending
- 2012-11-12 CN CN201280077004.9A patent/CN104955467A/zh active Pending
- 2012-11-12 WO PCT/IB2012/056344 patent/WO2014072771A1/en active Application Filing
- 2012-11-12 BR BR112015010639A patent/BR112015010639A2/pt not_active IP Right Cessation
- 2012-11-12 CA CA2890574A patent/CA2890574A1/en not_active Abandoned
- 2012-11-12 US US14/442,031 patent/US9855304B2/en not_active Expired - Fee Related
- 2012-11-12 MX MX2015005897A patent/MX2015005897A/es unknown
-
2013
- 2013-11-08 AR ARP130104120A patent/AR093425A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
US9855304B2 (en) | 2018-01-02 |
WO2014072771A1 (en) | 2014-05-15 |
BR112015010639A2 (pt) | 2017-07-11 |
MX2015005897A (es) | 2016-02-05 |
JP2016507216A (ja) | 2016-03-10 |
CA2890574A1 (en) | 2014-05-15 |
CN104955467A (zh) | 2015-09-30 |
US20150283186A1 (en) | 2015-10-08 |
RU2015122728A (ru) | 2017-01-10 |
EP2925333A1 (en) | 2015-10-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SV2017005367A (es) | Composiciones y métodos de uso para tratar trastornos metabólicos | |
AR093426A1 (es) | Uso de una cepa de lactobacillus rhamnosus para reducir la ganancia de peso o la resistencia a la insulina, o ambas cosas al mismo tiempo | |
BR112016018283A2 (pt) | Composição que compreende bifidobacterium animalis ssp. lactis | |
SV2015004969A (es) | Imidazo[1,2-a]piridincarboxamidas aminosustituidas y su uso | |
AR094025A1 (es) | Utilizacion de bifidobacterium animalis para el tratamiento o la prevencion de la ganancia de peso corporal y de la resistencia a la insulina | |
DOP2013000007A (es) | Pirimidinadas y triazinas condensadas y su uso | |
IN2015DN02826A (es) | ||
CL2011001939A1 (es) | Uso de lactobacillus helveticus cncm i-4095 para apoyar la perdida de peso y/o mantenimiento del peso en humanos y/o animales, particularmente para tratar la obesidad y trastornos metabólicos; y microorganismo de la cepa de lactobacillus helveticus cncm i-4095. | |
CL2013002210A1 (es) | Formulación prebiótica para consumo humano que comprende 2´-fucosilactosa, 3´-sialilactosa y 6´-sialilactosa, en que la cantidad en peso de 3´-sialilactosa es al menos igual de elevada que la cantidad de 2´-fucosilactosa; y método para modular o estimular la proliferación de bifidobacterias en el intestino humano. | |
EP3943092A3 (en) | Compositions for use in inducing differentiation of human brown adipocyte progenitors | |
NZ711956A (en) | Rice protein supplements | |
AR098703A1 (es) | Composición alimenticia para baño de oblea para helados y método para su elaboración | |
AR093425A1 (es) | Cepa de lactobacillus rhamnosus para reducir la acumulacion de grasa corporal | |
MX2017002584A (es) | Composicion y producto medicinal para reducir peso corporal y grasa corporal, y uso del producto. | |
PT3137635T (pt) | Estirpes de lactobacillus de ação rápida e sua utilização para melhoramento da estabilidade aeróbica da silagem | |
CL2011001937A1 (es) | Uso de la cepa de lactobacillus rhamnosus cncm i-4096 para apoyar la pérdida de peso y/o mantenimiento del peso en humanos y/o animales, específicamente para el tratamiento de la obesidad. | |
ES2711427T8 (es) | Lactobacillus reuteri ATCC PTA 6475 para su uso en la prevención o el tratamiento de la pérdida ósea en mamíferos | |
WO2015121458A3 (fr) | Utilisations de compositions comprenant du bifidobacterium animalis ssp. lactis lmg p-28149 | |
MY171048A (en) | Pharmaceutical composition for preventing or treating amyloid beta peptide-associated diseases or conditions | |
MX2017001632A (es) | Mioinositol y probioticos, y uso de estos. | |
MX345948B (es) | Uso de cepas mutantes resistentes a la nisina de lactobacilos para reducir la post-acidificación en los productos alimenticios. | |
CL2016001752A1 (es) | Administración de vitamina b6 materna para la prevención del aumento de la adiposidad, el sobrepeso o la obesidad en la descendencia | |
MX2015002290A (es) | Una composicion alimenticia que comprende una mezcla de permeado lacteo y harina vegetal. | |
SG11201804602SA (en) | Nutritional composition | |
CR20190142A (es) | Composiciones de tesofensina |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |